Anticancer agent 75
Modify Date: 2024-01-09 18:43:16
Anticancer agent 75 structure
|
Common Name | Anticancer agent 75 | ||
|---|---|---|---|---|
| CAS Number | 2414491-13-5 | Molecular Weight | 332.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H24N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Anticancer agent 75Anticancer agent 75 is a potent anticancer agent. Anticancer agent 75 shows cytotoxicity and selectivity in cancer cell lines. Anticancer agent 75 shows cytotoxicity to normal human kidney cell lines is at least 35 times lower than that of the Doxorubicin standard. Anticancer agent 75 shows good activity of antiplasmodial[1]. |
| Name | Anticancer agent 75 |
|---|
| Description | Anticancer agent 75 is a potent anticancer agent. Anticancer agent 75 shows cytotoxicity and selectivity in cancer cell lines. Anticancer agent 75 shows cytotoxicity to normal human kidney cell lines is at least 35 times lower than that of the Doxorubicin standard. Anticancer agent 75 shows good activity of antiplasmodial[1]. |
|---|---|
| Related Catalog | |
| Target |
Topoisomerase II |
| In Vitro | Anticancer agent 75 (Compounds 3h) shows good anticancer activity and at least 35 times less toxic than Doxorubicin[1]. Anticancer agent 75 (Compounds 3h) inhibits cancer cell growth with IC50 values of 333.83 µM, 13.39 µM, 15.31 µM, 15.58 µM, and 4.90 µM for HEK-293, HuCCA-1, A549, HepG2, and MOLT-3, respectively[1]. |
| References |
| Molecular Formula | C22H24N2O |
|---|---|
| Molecular Weight | 332.44 |